Trial intelligence / Profile preview

Brimonidine vs Brinzolamide Adjunct to Latanoprost in Glaucoma

NCT00440141Phase 4Completed

Sponsor
Allergan
Start
Jul 2006
Primary completion
Mar 2007
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of brimonidine in Glaucoma, ocular hypertension, sponsored by Allergan. Started Jul 2006; status: completed.

02

Drugs

brimonidine
03

Conditions

Glaucomaocular hypertension

Beyond the preview

Go deeper on NCT00440141.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00440141.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call